Regulatory Affairs Services Provider in Portugal
Portugal offers a well-regulated and mature pharmaceutical market within the European Union, providing access not only to a national healthcare system but also alignment with broader EU regulatory frameworks. Market entry is structured and predictable, but it requires strict compliance with European Medicines Agency standards and national authority requirements. Approval timelines, pricing controls, and local regulatory expectations demand a precise and well-executed strategy.
DDReg provides specialized Regulatory Affairs Services in Portugal, supporting pharmaceutical companies with compliant submissions, efficient approvals, and end-to-end regulatory execution aligned with EU and national requirements.
Regulatory Framework in Portugal
Pharmaceutical regulation in Portugal is governed by INFARMED – National Authority of Medicines and Health Products.
The authority is responsible for product authorization, pricing, and reimbursement decisions, pharmacovigilance oversight, and market surveillance. Portugal operates within the European Union regulatory framework, meaning approvals may follow centralized, decentralized, or national procedures depending on the product strategy.
Regulatory Affairs Services in Portugal
DDReg delivers comprehensive Pharmaceutical Regulatory Affairs in Portugal, designed to support efficient approvals and long-term compliance within the EU framework.
Our services include:
- Regulatory strategy and market entry planning for Portugal and EU pathways
- Product registration support via centralized, decentralized, or national procedures
- CTD/eCTD dossier preparation, publishing, and compliance review
- Dossier gap analysis aligned with INFARMED and EMA requirements
- Submission management and coordination with regulatory authorities
- Regulatory query handling and response support
- Pricing and reimbursement support
- Coordination with local representatives where required
- Lifecycle management, including variations, renewals, and updates
- Labeling and artwork compliance in line with EU requirements
- Regulatory intelligence and ongoing compliance monitoring
Our focus remains on submission accuracy, regulatory alignment, and execution efficiency.
Regulatory Affairs Process in Portugal
Market access in Portugal depends on regulatory approval through the appropriate EU or national pathway. Applications are submitted in eCTD format and evaluated either by the European Medicines Agency or through national or decentralized procedures involving INFARMED.
Pricing and reimbursement decisions are managed at the national level and play a critical role in commercialization timelines. Regulatory success depends on correct pathway selection, dossier completeness, and alignment with both EU and local requirements.
Why Choose DDReg for Regulatory Affairs Services in Portugal ?
DDReg brings a structured and execution-focused approach to regulatory operations in Portugal.
- Strong understanding of INFARMED and EU regulatory frameworks
- Experience across centralized, decentralized, and national procedures
- Focus on submission-ready, compliant dossiers
- Integrated approach to regulatory and pricing strategy
- End-to-end support from submission to lifecycle management
This ensures consistent progress from regulatory planning to approval and beyond.
Global Reach Explorer
Find Your Solution
Our Regulatory Affairs Consulting Services in Portugal portfolio covers:
Regulatory Strategies
The pharmaceutical industry operates under stringent regulations to ensure the safety, efficacy, and quality...
New Product Marketing Authorizations
Navigating marketing authorization is a complex and time-sensitive process. Every country has its own regulatory framework...
Gap Analysis and Remediation
In the highly regulated pharmaceutical industry, maintaining compliance is critical. Regulatory gap analysis helps identify deficiencies in technical documentation...
Regulatory Due Diligence
Regulatory issues arise unexpectedly and can create significant strain on a company’s resources. As such, it is advisable for all companies to carry out regular and frequent regulatory due diligence and audits...
API & DMF services
Drug Master Files (DMFs) contain confidential and detailed information regarding API processes—from manufacturing to storage. DDReg’s DMF Services deliver precise...
CMC Advisory
DDReg’s CMC services are dedicated to assisting customers in developing robust and an efficient regulatory strategy through all development phases - authoring...
Post Approval Life Cycle Management
Maximize product value with expert pharma lifecycle management. Our dedicated team ensures that your product remains on shelves and compliant with ever-evolving regulations through strategic post-approval management...
Certification Services
Partner with DDReg to navigate the complex process of regulatory certification of pharmaceutical...
ANDA and MA Holder Services
Our comprehensive services support both Abbreviated New Drug Applications (ANDA) and Marketing Authorization processes.
Publishing & Submission
Our comprehensive digital solution transforms traditional paper dossier submissions into a streamlined electronic format. With robust infrastructure and cutting‐edge management processes...
